2Moriwaki H, Miwa Y, Tajika M, et al. Branched-chain amino acids as a protein-and energy-source in liver cirrhosis. Biochem Biophys Res Commun,2004,313(2) :405-409.
3Muto Y, Sato S, Watanabe A, et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepato1,2005,3 (7) :705-713.
4Marchesini G, Bianehi G, Merli M, et al. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology, 2003,124 ( 7 ) : 1792-1801.
5Okabayashi T, Nishimori I, Sugimoto T, et al. Effects of branched- chain amino acids-enriched nutrient support for patients undergoing liver resection for hepatocellular carcinoma. J Gastroenterol Hepatol,2008,23 ( 12 ) : 1869-1873.
6Poan RT, Yu WC, Fan ST, et al. Long-term oral branched chain amino acids in patients undergoing chemoembolization for hepato- cellular carcinoma: a randomized trial. Aliment Pharmacol Ther, 2004,19(7) :779-788.
7Tomiya T, Omata M, Fujiwara K. Significance of branched chain amino acids as possible stimulators of hepatocyte growth factor. Biochem Biophys Res Commnn,2004,313(2) :411-416.
8Holecek M. Three targets of branched-chain amino acid supple- mentation in the treatment of liver disease. Nutrition, 2010,26 (5) :482-490.
9Kobayashi M, Ikeda K,Arase Y, et al. Inhibitory effect of branchedchain amino acid granules on progression of compensated liver cirrhosis due to hepatitis C virus. J Gastroenterol,2008,43 (1) :63-70.
10Kawaguchi T, Nagao Y, Matsuoka H, et al. Branched-chain amino acid-enriched supplementation improves insulin resistance in patients with chronic liver disease. Int J Mol Med, 2008,22 ( 1 ) : 105-112.